James Caggiano

Chief Executive Officer at Evolve Biologics

James Caggiano has an extensive work experience spanning over three decades. James currently serves as the Chief Executive Officer of Evolve Biologics since January 2021. Prior to their current role, they worked as the CEO of Dendreon from June 2017 to November 2019. Before that, they held the position of President at Valeant Pharmaceuticals from May 2015 to June 2017.

James also has a strong background in the pharmaceutical industry, having worked at Allergan from May 2008 to December 2013. During their tenure at Allergan, they served as General Manager of the Obesity Business and was responsible for various functions including Medical Devices, DTC Advertising, Strategy, Business Development, and Leadership. James also held the position of Vice President of Sales and Marketing, overseeing Bariatrics, DTC Advertising, Strategy, and Leadership.

Prior to Allergan, James gained experience at Dendreon as the Vice President of Sales and Marketing from 2004 to 2008. Here, they focused on Biotech, Commercialization, Market Development, Product Launch, and Urology. Before that, they worked at Abbott as the Vice President of Sales and Marketing for Cardiovascular Devices from February 2002 to October 2004, where they managed Strategy, Integration, Sales, and Marketing.

James began their career in the pharmaceutical industry at Abbott Laboratories--TAP Pharmaceuticals in 1991. James held the role of Director of Lupron Marketing, overseeing Urology, Gynecology, Marketing, and Strategy. Prior to their experience in the pharmaceutical industry, James served as an Armor Officer in the US Army from 1986 to 1990.

Overall, James Caggiano has held various leadership positions in the pharmaceutical industry, showcasing their expertise in strategic planning, business development, sales, and marketing.

James Caggiano completed their Bachelor of Science degree in Agriculture and Life Sciences with a focus on Business at Cornell University from 1982 to 1986. Subsequently, they pursued their Master of Business Administration (MBA) degree at Northwestern University's Kellogg School of Management from 1998 to 2000.

Links

Timeline

  • Chief Executive Officer

    January, 2021 - present